東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Hybrid, multidimensional magnetic re...

Sadinski, Meredith.

FindBook

Google Book

Amazon

博客來

Hybrid, multidimensional magnetic resonance imaging of prostate cancer.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Hybrid, multidimensional magnetic resonance imaging of prostate cancer./
作者:	Sadinski, Meredith.
面頁冊數:	116 p.
附註:	Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.
Contained By:	Dissertation Abstracts International77-10B(E).
標題:	Medical imaging. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10129564
ISBN:	9781339874555

Hybrid, multidimensional magnetic resonance imaging of prostate cancer.
Sadinski, Meredith.

Hybrid, multidimensional magnetic resonance imaging of prostate cancer. - 116 p.

Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.

Thesis (Ph.D.)--The University of Chicago, 2016.

Prostate cancer is the most commonly diagnosed cancer among men, estimated to affect one in six American men. Despite its high prevalence, nearly 50% of prostate cancer is insignificant and unrelated to cause of death of the patient. It is thus of paramount importance that physicians are able to make informed decisions on course of treatment for prostate cancer patients; an aggressive treatment option such as radiation therapy or surgery with risk of adverse side effects is necessary for high grade cancers while active surveillance may be sufficient for lower grade cancers. Current methods for assessing the aggressiveness of prostate cancer are insufficient and repeat biopsies or histological analysis of prostatectomy specimens often show disagreement with initial staging. MRI has become a useful, non-invasive tool for prostate cancer screening. A clinical multiparametric MRI (mp-MRI) exam typically includes T1, T2 and apparent diffusion coefficient (ADC) maps, extracted from T1-weighted, T2-weighted and diffusion-weighted MRI (DWI) sequences, respectively. However, the efficacy of PCa MRI is limited by the inability to distinguish the signal from cancerous foci from the background signal from normal tissue using standard, clinical MRI sequences.

ISBN: 9781339874555Subjects--Topical Terms:

3172799
Medical imaging.

Hybrid, multidimensional magnetic resonance imaging of prostate cancer.
LDR:03220nmm a2200277 4500 001 2074347
005 20160926125818.5
008 170521s2016 ||||||||||||||||| ||eng d
020 $a 9781339874555
035 $a (MiAaPQ)AAI10129564
035 $a AAI10129564
040 $a MiAaPQ $c MiAaPQ
100 1 $a Sadinski, Meredith. $3 3189660
245 1 0 $a Hybrid, multidimensional magnetic resonance imaging of prostate cancer.
300 $a 116 p.
500 $a Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.
500 $a Advisers: Gregory Karzmar; Aytekin Oto.
502 $a Thesis (Ph.D.)--The University of Chicago, 2016.
520 $a Prostate cancer is the most commonly diagnosed cancer among men, estimated to affect one in six American men. Despite its high prevalence, nearly 50% of prostate cancer is insignificant and unrelated to cause of death of the patient. It is thus of paramount importance that physicians are able to make informed decisions on course of treatment for prostate cancer patients; an aggressive treatment option such as radiation therapy or surgery with risk of adverse side effects is necessary for high grade cancers while active surveillance may be sufficient for lower grade cancers. Current methods for assessing the aggressiveness of prostate cancer are insufficient and repeat biopsies or histological analysis of prostatectomy specimens often show disagreement with initial staging. MRI has become a useful, non-invasive tool for prostate cancer screening. A clinical multiparametric MRI (mp-MRI) exam typically includes T1, T2 and apparent diffusion coefficient (ADC) maps, extracted from T1-weighted, T2-weighted and diffusion-weighted MRI (DWI) sequences, respectively. However, the efficacy of PCa MRI is limited by the inability to distinguish the signal from cancerous foci from the background signal from normal tissue using standard, clinical MRI sequences.
520 $a This dissertation investigates a hybrid, multidimensional imaging approach to prostate MRI, which looks at how standard measures (ADC, T1, T2) react to changes in sequence parameters (TE, TR, b). This enables a selective filtration of particular tissue components and subsequent emphasis of differences in tissue structure indicative of prostate cancer. My results suggest that using hybrid imaging to identify differences in tissue structure could lead to better differentiation between normal tissue, aggressive prostate cancer and benign tumors or conditions. Hybrid imaging provides structural information undetectable using conventional mp-MRI. It may therefore provide independent, diagnostic information that compliments ADC, T1 or T2 values and increase diagnostic accuracy when used in combination with conventional mp-MRI. Structural markers such as decreased luminal volume, increased cellularity, and nucleomegaly become more prominent with increased Gleason Score. Hybrid MRI may therefore be useful for noninvasively determining Gleason Score in the future.
590 $a School code: 0330.
650 4 $a Medical imaging. $3 3172799
690 $a 0574
710 2 $a The University of Chicago. $b Medical Physics. $3 1671030
773 0 $t Dissertation Abstracts International $g 77-10B(E).
790 $a 0330
791 $a Ph.D.
792 $a 2016
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10129564